No Data
No Data
Drug Compounders Fight Drugmaker Efforts to Push Them Out of Market for GLP-1 Medications
Trump's Made His Health Picks. What They Mean for the Sector. -- Barrons.com
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
(LLY) - Analyzing Eli Lilly's Short Interest
Hims & Hers up 18% Amid Optimism for Compounders With Makary FDA Pick
S&P 500, Dow Hit Records Right After Open | Live Stock
No Data
No Data
MonkeyGee OP : not good that LLY gave up the gain this morning!
MonkeyGee OP : below 745 now. if it doesn't recover by end of day good luck!
MonkeyGee OP : LLY 742 now
MonkeyGee OP : Suits will take LLY down soon. PFE is up and LLY is down